Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action (Q36157999)

12 August 2017

1 reference

title

Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action (English)

1 reference

12 August 2017

1 reference

Jose S Pulido

1

1 reference

PubMed ID

15947803

12 August 2017

Donald Sanders

series ordinal

2

1 reference

PubMed ID

15947803

12 August 2017

Reinhard Klingel

series ordinal

3

1 reference

12 August 2017

1 June 2005

1 reference

Canadian Journal of Ophthalmology

12 August 2017

1 reference

12 August 2017

40

1 reference

12 August 2017

3

1 reference

12 August 2017

332-340

1 reference

Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Missense variations in the fibulin 5 gene and age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Ultrastructural aging of the RPE-Bruch's membrane-choriocapillaris complex in the D-galactose-treated mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Age-related Macular Degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

A hemodynamic model of the pathogenesis of age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Current concepts in the pathogenesis of age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Ocular perfusion and age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Complement factor H polymorphism and age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Optical coherence tomography of fundus abnormalities associated with type II membranoproliferative glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Association between C-reactive protein and age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

Change in hemorrheological and biochemical parameters following membrane differential filtration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980076-6

10.1016/S0008-4182(05)80076-6

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15947803